Russell Investments »

Monte Rosa Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.8k 2.6k 3.74
2023-06-30 $9.8k 1.4k 6.85
2023-03-31 $11k 1.4k 7.79
2022-12-31 $11k 1.4k 7.61
2022-09-30 $11k 1.4k 7.69

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Eli Lilly And Company Common Stock (LLY)
Unitedhealth Group Common Stock (UNH)
Welltower Common Stock (WELL)
Prologis Common Stock (PLD)
Digital Realty Trust Common Stock (DLR)
J P Morgan Chase And Common Stock (JPM)

View all positions for Russell Investments

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
BlackRock
Aisling Capital Management
Alphabet
Citadel Advisors
Geode Capital Management
Vestal Point Capital
State Street Corporation
Parkwood
ExodusPoint Capital Management

View all funds holding Monte Rosa Therapeutics